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Abstract
Purpose: Lipedema is a chronic, common but underdiagnosed disease masquerading
obesity, with female predominance, characterized by disproportional abnormal adipose
tissue distribution of the lower and also upper extremities. The present study was
designed to determine whether lipedema is associated with three-dimensional (3D)
speckle-tracking echocardiography (3DSTE)-derived left ventricular (LV) deformation
abnormalities, and to assess the effects of 1-hour use of medical compression stock-
ings (MCS).
Methods: The present study comprised 19 female patients with lipedema (mean age:
42.2 ± 12.4 years), compared to 28 age-matched healthy female controls (mean age:
42.0 ± 9.8 years).
Results: Lipedema patients showed larger left atrial and LV dimensions and greater
LV ejection fraction than controls, without significant difference in other echocardi-
ography variables. Lipedema patients had greater 3DSTE-derived global and mean
segmental LV circumferential and area strains than controls. Following 1-hour use of
wearing MCS, neither global and nor mean segmental LV strains showed significant
impairment or improvement.
Conclusions: Increased LV strains could be compensatory effects maintaining LV
pumping function in lipedema. Short-term wearing of MCS has no global effect on LV
strains.
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1 | INTRODUCTION
Lipedema is a chronic, common but underdiagnosed and progressive
disease masquerading obesity, with female predominance, character-
ized by disproportional abnormal adipose tissue distribution between
the lower and also upper extremities.1,2 Although treatment strategies
of this disease are debated, the use of medical compression stockings
(MCS) is a part of regular treatment in lipedema.3 The development of
lipedema may be partly explained by a polygenic background combined
with hormonal, microvascular, and lymphatic disorders.4 Although
patients with lipedema do not display severe cardiovascular profile,4,5
several cardiac abnormalities including left ventricular (LV) rotational
abnormalities and dilated mitral annulus with impaired function
could be demonstrated by three-dimensional (3D) speckle-tracking
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echocardiography (3DSTE).6,7 This relatively newly developed non-
invasive imaging technique provides quantitative assessment of myo-
cardial contractility by strain variables from acquired 3D echocardio-
graphic datasets.8,9 The present study was designed to determine
whether lipedema is associated with 3DSTE-derived LV deformation
abnormalities, and to assess the effects of wearing MCS for 1 hour.
2 | METHODS
2.1 | Patient population
The present study comprised 19 female patients with stage 2 lipedema
(mean age: 42.2 ± 12.4 years, body mass index: 34.1 ± 7.0 kg/m2),
compared to 28 age-matched healthy female controls (mean age: 42.0
± 9.8 years, body mass index: 23.3 ± 4.7 kg/m2). None of the lipedema
patients and controls had risk factors or any other disease that could
theoretically affect the results. No medication was used by any subject.
Lipedema was diagnosed and characterized on the basis of its typical
clinical features (stove pipe legs, non-pitting edema, cuffing sign, spon-
taneous or minor trauma induced pain perception, easy bruising).3,10
Lipedema patients were referred by the Phlebolymphology Unit of the
Department of Dermatology and Allergology, University of Szeged for
routine echocardiographic examination extended with 3DSTE. Data
originate from the MAGYAR-Path Study (Motion Analysis of the heart
and Great vessels bY three-dimensionAl speckle-tRacking echocardiog-
raphy in Pathological cases), which was organized to assess diagnostic
and prognostic value of 3DSTE-derived variables. The current study
was approved by the human research committee of the University of
Szeged, Faculty of Medicine. It complied with the Declaration of Hel-
sinki and all participants gave informed consent.
2.2 | Two-dimensional Doppler echocardiography
Complete two-dimensional (2D) transthoracic echocardiography
examinations extended with Doppler measurements were performed
in all healthy subjects and lipedema patients according to recent
guidelines and practices.11 Examinations were performed with an
Artida ultrasonographic system (Toshiba Medical Systems, Tokyo,
Japan) with its PST-30SBP (1-5 MHz) phased-array transducer. Fol-
lowing chamber quantifications, transmitral E/A flow velocities were
measured and valvular abnormalities were detected if present.
2.3 | Three-dimensional speckle-tracking
echocardiography
The same echocardiography machine was used for 3DSTE assess-
ments. Full volume 3D pyramid-shaped echocardiographic datasets
were acquired by a PST-25SX matrix-array transducer. During data
acquisition, six “as narrow as possible” wedge-shaped sub-volumes
were recorded during six RR intervals and a single breath-hold. Then,
the software merged them into a pyramid-shape 3D volume. Using
these datasets, automatic offline analysis was performed in all cases.
Apical four-chamber (AP4CH) and two-chamber (AP2CH) views and
three cross-sectional views at different LV levels were automatically
reconstructed from the 3D datasets using the 3D Wall Motion Track-
ing software version 2.7 (Toshiba Medical Systems, Tokyo, Japan)
(Figure 1). Following optimization, markers were set to the edges of
the mitral annulus and the apical LV endocardium by the examiners.
Then, the software automatically reconstructed the LV endocardial
surface and a 3D LV model was created.8,9
2.4 | Assessment of 3DSTE-derived LV volumes
and strains
LV end-diastolic (EDV) and end-systolic (ESV) volumes, LV ejection
fraction (EF), and LV mass were measured using the above-mentioned
3D LV model. Using the same acquired 3D echocardiographic
datasets, several strains were measured as listed below8,9:
Unidirectional (unidimensional) strains:
• radial strain (RS)—thickening and thinning of the segment
• longitudinal strain (LS)—lengthening and shortening of the segment
• circumferential strain (CS)—widening and narrowing of the
segment
Multidirectional (multidimensional) or complex strains:
• area strain (AS)—combination of LS and CS
• 3D strain (3DS)—combination of RS, LS and CS
Segmental strain measurements were performed using the
16-segment LV model. Moreover, global and mean segmental strains
were also calculated.8,9
2.5 | Study protocol
The study protocol was the same as reported in previous studies.6,7
First, 2D Doppler echocardiography was performed with 3DSTE in all
patients with lipedema. Then, MCSs were put on and worn for
60 minutes. A second echocardiographic examination was performed
before taking the MCSs off. During the 60-minute use of MCS, physi-
cal exercise, sitting with straight legs, standing and consuming any
meal or beverage were not allowed. Stable room temperature
(21-22C) and relative humidity (45-50%) were ensured during the
measurements. VenoTrain CuraFlow flat-knitted black-colored ccl
2 (23-32 mmHg) (Bauerfeind, Zeulenroda, Germany) stockings were
applied consisting of 73% polyamide and 27% elastane. For interface
pressure measurement between the skin and the compression mate-
rial, Picopress device (Microlab Elettronica, Nicolò, Italy) was used at
B1 point in standing position with a mean pressure of 22.12
± 3.54 mmHg in lipedema patients.12
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2.6 | Statistical analysis
Two-tailed tests were used for comparisons and P value <.05 was
defined as significant. Continuous data were shown as mean values ±
SD, while categorical data were presented as counts and percentages.
To compare categorical variables, Fisher's exact test was used. For
continuous variables, Shapiro-Wilk test was performed to test the
variable distribution. If distribution was normal, Student t test was
used. If not, datasets were compared using Mann-Whitney-Wilcoxon
test. RStudio (RStudio Team, RStudio Inc., Boston, Massachusetts,
2015) was used for statistical analysis.
Offline data extraction and analysis were performed by using the
MatLab 8.6 (2015) software package (The MathWorks Inc., Natick,
Massachusetts).
F IGURE 1 Apical four-chamber,
A and two-chamber, B and cross-
sectional views at apical (C3),
midventricular (C5) and basal (C7) left
ventricular (LV) levels automatically
selected from an acquired three-
dimensional echocardiographic
dataset. LV three-dimensional cast, D;
corresponding LV volumetric
parameters, E; and segmental LV
longitudinal strain curves, F
TABLE 1 Two-dimensional echocardiographic data of patients with lipedema and controls
Controls Lipedema patients
P-value(n = 28) (n = 19)
LA diameter (mm) 34.4 ± 4.1 39.6 ± 4.1 <.001
LV end-diastolic diameter (mm) 45.8 ± 3.2 49.8 ± 3.2 <.001
LV end-diastolic volume (ml) 92.3 ± 14.1 119.2 ± 18.1 <.001
LV end-systolic diameter (mm) 32.7 ± 11.1 30.8 ± 2.7 .9
LV end-systolic volume (ml) 32.7 ± 8.6 38.3 ± 8.8 .02
Interventricular septum (mm) 8.8 ± 1.3 8.6 ± 0.9 .4
LV posterior wall (mm) 9.3 ± 2.0 8.7 ± 0.9 .3
E (cm/s) 77.7 ± 17.2 86.0 ± 18.0 .1
A (cm/s) 65.6 ± 14.8 72.9 ± 18.9 .1
E/A 1.2 ± 0.3 1.3 ± 0.4 .8
LV ejection fraction (%) 64.3 ± 4.3 68.3 ± 3.6 .002
Abbreviations: A, late transmitral flow velocity; E, early transmitral flow velocity; LA, left atrium; LV, left ventricle.
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3 | RESULTS
3.1 | Two-dimensional echocardiography
Left atrial (LA) and LV dimensions, and LV ejection fraction were
greater in lipedema patients than in controls, without significant dif-
ference in the other echocardiography variables (Table 1).
3.2 | Three-dimensional speckle-tracking
echocardiography
Although 3DSTE-derived data acquisition was performed before and
after the use of MCS, 3DSTE measurement could not be performed
from the datasets acquired 1-hour after the use of MCS in 2 lipedema
patients (Tables 2 and 3). Three-dimensional speckle-tracking
echocardiography-derived volumetric measurements confirmed 2D
echocardiographic assessments. Global and mean segmental LV-CS
and LV-AS were greater in lipedema patients than in controls before
the use of MCS. Following 1-hour use of MCS, none of global and
mean segmental LV strains showed significant impairment or improve-
ment in lipedema patients. At segmental analysis, only midventricular
LV strains were significantly greater in lipedema patients than in con-
trols. Apical segmental LV-CS, LV-AS and LV-3DS further increased
after 1-hour use of MCS as compared to resting data in lipedema
patients.
4 | DISCUSSION
We used 3DSTE to assess global and segmental LV strains in lipedema
patients and controls. This new non-invasive, angle-independent tech-
nique is feasible to quantify not only LV rotational abnormalities, but
also global and segmental LV contractility by objective features called
strains in the 3D space.8,9 It has been validated against other imaging
techniques for LV strains and volumes,13-17 and normal reference
values of LV strains are available.18
Previously, only cardiovascular profile data of lipedema patients
was available in literature.4 Low prevalence of diabetes despite higher
body mass index has been demonstrated, and majority of lipedema
patients had a normal lipid profile. Only one-third of lipedema cases
with stages 2 or 3 had hypertension according to literature.4 At this
moment, only a limited number of clinical studies are available regard-
ing lipedema-associated cardiovascular alterations.6,7,19 Although rou-
tine echocardiography shows no significant alterations, recent
developments in imaging techniques generated new methodologies,
including 3DSTE, allowing detailed analysis for deeper insights into
the heart mechanics.6-9 Not only LV rotational abnormalities and
changes in contractility can be quantified with 3DSTE, but alterations
of dimension and function of atria and valvular annuli can be charac-
terized non-invasively in greater details.6-9
The result of the present study could be partially explained in the
context of recent findings. Increased aortic stiffness has been demon-
strated in lipedema.19 Moreover, LV apical rotation and twist were
TABLE 2 Comparison of three-dimensional speckle-tracking echocardiography-derived global and mean segmental left ventricular strains in
patients with lipedema and controls
Controls Lipedema patients before the use of MCS Lipedema patients after 1-hour use of MCS
(n = 28) (n = 19) (n = 17)
3DSTE-derived LV volumetric parameters
EDV (ml) 74.0 ± 13.3 86.6 ± 17.3* 90.5 ± 18.0*
ESV (ml) 32.1 ± 6.6 33.4 ± 6.9 34.9 ± 8.3
EF (%) 56.3 ± 6.5 61.1 ± 5.5* 61.5 ± 3.9*
3DSTE-derived LV global strains
Radial (%) 24.3 ± 10.5 28.3 ± 11.1 24.9 ± 10.3
Circumferential (%) −25.9 ± 5.4 −30.2 ± 4.0* −30.2 ± 3.5*
Longitudinal (%) −17.2 ± 2.3 −18.4 ± 2.6 −18.5 ± 1.8
3D (%) 26.6 ± 10.3 30.3 ± 10.9 27.7 ± 10.7
Area (%) −39.7 ± 5.2 −43.1 ± 4.7* −43.7 ± 3.4*
3DSTE-derived LV mean segmental strains
Radial (%) 26.8 ± 9.8 31.1 ± 10.9 27.6 ± 10.0
Circumferential (%) −27.0 ± 5.4 −30.9 ± 4.3* −30.9 ± 3.4*
Longitudinal (%) −17.9 ± 2.2 −19.2 ± 2.7 −19.1 ± 1.8
3D (%) 29.0 ± 9.7 33.0 ± 10.9 30.2 ± 10.7
Area (%) −40.8 ± 5.1 −44.2 ± 4.9* −44.5 ± 3.2*
Abbreviations: EDV, end-diastolic volume; ESV, end-systolic volume; EF, ejection fraction; LV, left ventricular; MCS, medical compression stockings;
3DSTE, three-dimensional speckle-tracking echocardiography; 3D, three-dimensional.
*P < .05 vs controls.
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found to be significantly reduced in lipedema patients with severe LV
rotational abnormalities in some (14%) cases.6 Due to a known close
relationship between LV rotational mechanics and aortic stiffness,
even in healthy subjects,20 these abnormalities could be partially
explained by each other. Moreover, direct effects of non-
cardiomyocytes with mesenchymal cells and adipose tissue deposi-
tions could not be excluded, which can be the topic of further investi-
gations.3 In spite of these findings, LV-EF was increased in lipedema
patients as compared to matched controls in the present study, which
could be explained by increased LV strains suggesting hyper-
contractility of the LV in certain directions to maintain pumping func-
tion as a compensatory effect despite LV rotational abnormalities. LV
strains are diminished in most of diseases, but in some disorders or
states (for instance in acromegaly or in elite athletes),21,22 similarly to
the findings of the present study, hypercontractility (increased global
or regional strains) has been demonstrated and considered as a com-
pensating mechanism.21 These alterations suggest specific lipedema-
related/associated cardiomyopathy, which warrants further investiga-
tion in this common but underdiagnosed disorder.
4.1 | Limitations
There are several limiting factors affecting the results:
• Lipedema is a rare disease that can be either underdiagnosed or
misdiagnosed with similar diseases like obesity and lymphedema.
Therefore, recruiting lipedema patients without known comorbid-
ity is difficult, resulting in the relatively small population sample of
lipedema patients.1-3
• The duration of the disease and its effects on the evaluated vari-
ables were not examined.
• There were some important technical limitations, including lower
spatial and temporal resolution of 3DSTE as compared to 2D
echocardiography.8
• LV strains show some vendor-dependency, and differences are
present in 2DSTE- and 3DSTE-derived variables as well.17,23 How-
ever, 3DSTE-derived LV volumetric and strain assessments have
been validated, which is why the present study included no repro-
ducibility study.13-17 Moreover, normal reference values of 3DSTE-
derived LV strains are available.18
• We did not perform 3DSTE-derived assessment of other heart
chambers.8
• Finally, comparison of 2D echocardiography-derived LV vol-
umes and that of measured by 3DSTE was not the aim of this
study.
5 | CONCLUSION
Lipedema patients showed greater LV strains than controls, which
could be a compensatory mechanism maintaining LV pumping
function. Wearing MCS for 1 hour had no global effects on LV
strains.
TABLE 3 Comparison of three-dimensional speckle-tracking echocardiography-derived segmental left ventricular strains in patients with
lipedema and controls
Controls Lipedema patients before the use of MCS Lipedema patients after 1-hour use of MCS
(n = 28) (n = 19) (n = 17)
RSbasal (%) 33.1 ± 15.5 35.9 ± 16.7 30.9 ± 14.2
RSmid (%) 27.4 ± 10.2 35.8 ± 11.6* 29.1 ± 11.0
RSapex (%) 16.6 ± 7.7 16.7 ± 8.3 20.4 ± 9.0
CSbasal %) −24.4 ± 5.6 −27.7 ± 8.0 −27.6 ± 5.8
CSmid (%) −26.7 ± 6.1 −32.7 ± 8.0* −31.4 ± 4.2*
CSapex (%) −31.6 ± 9.8 −33.2 ± 8.0 −34.9 ± 6.2†
LSbasal (%) −22.1 ± 4.6 −19.9 ± 5.0 −21.0 ± 3.8
LSmid %) −14.4 ± 2.8 −18.0 ± 3.3* −17.3 ± 4.5
LSapex (%) −16.9 ± 5.3 −20.0 ± 4.9 −19.1 ± 2.2
3DSbasal (%) 35.8 ± 14.9 38.3 ± 17.4 34.4 ± 15.3
3DSmid (%) 28.8 ± 10.3 37.2 ± 11.1* 31.4 ± 11.6
3DSapex (%) 18.2 ± 7.9 18.6 ± 9.0 22.2 ± 9.7
†
ASbasal (%) −40.4 ± 6.6 −41.3 ± 8.9 −42.2 ± 6.5
ASmid (%) −38.0 ± 6.4 −44.8 ± 4.6* −43.8 ± 5.4*
ASapex (%) −44.4 ± 10.7 −47.6 ± 9.4 −48.9 ± 5.5†
Abbreviations: AS, area strain; CS, circumferential strain; LS, longitudinal strain; MCS, medical compression stockings; RS, radial strain; 3DS,
three-dimensional strain.
*P < .05 vs controls.
†P < .05 vs lipedema POST group.
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